Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Vice President, Science Policy at Biotechnology Innovation Organization (BIO) (retd.)
Kay Holcombe, Senior Vice President for Science Policy at the Biotechnology Innovation Organization, works with the organization on all major policy initiatives, with a particular focus on regulatory policy. Prior to joining BIO, she was Vice President, FDA Alliances and Federal Agency Relations, at Sanofi and Vice President for Government Relations at Genzyme Corporation. Kay works with government relations, policy, and legal staff as well as with principals of BIO member companies to develop and implement policies that advance the public health through biotechnology and to develop appropriate responses to government initiatives that affect the biopharmaceutical industry broadly.
Before joining Genzyme in 2006, Kay spent 8 years as Executive Vice President of Policy Directions Inc., a government relations firm specializing in strategic planning and legislative and regulatory advocacy regarding health care and related issues. She represented a variety of clients in the pharmaceutical and biotechnology, food, and consumer products industries and in academia, providing strategic advice and assistance and advocacy at federal regulatory and funding agencies and in the U.S. Congress.
Kay received her B.S. in chemistry education from the University of Illinois and her M.S. in chemistry from the University of Virginia. She graduated with honors and was elected to Phi Beta Kappa, Phi Kappa Phi, and Iota Sigma Pi.